LGND logo

Ligand Pharmaceuticals Incorporated (LGND) Quick Ratio

Annual Quick Ratio

12.72
+10.19+402.77%

31 December 2023

1-Year Change

+402.77%
LGND annual quick ratio is up +402.77% year-on-year

3-Year Change

+168.35%
LGND annual quick ratio is up +168.35% over the past 3 years

All-time High

65.66
LGND annual quick ratio is currently -80.63% below its historical high of 65.66

Sector Rank

97.64%
LGND annual quick ratio is higher than 97.64% of companies in Healthcare sector

Annual Quick Ratio Formula

Current Assets - Inventory
Current Liabilities
Annual Current Ratio14.15
LGND annual current ratio is 14.15
Annual Debt To Equity0.00
LGND annual debt to equity ratio is 0.00
Annual Book Value$700.91 M
LGND annual book value is $700.91 million

LGND Quick Ratio Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Quick Ratio

11.95
-4.09-25.50%

30 September 2024

1-Year Change

-17.81%
LGND quarterly quick ratio is down -17.81% year-on-year

3-Year Change

+8.64%
LGND quarterly quick ratio is up +8.64% over the past 3 years

All-time High

65.66
LGND quarterly quick ratio is currently -81.80% below its historical high of 65.66

Sector Rank

97.06%
LGND quarterly quick ratio is higher than 97.06% of companies in Healthcare sector
Quarterly Current Ratio12.49
LGND quarterly current ratio is 12.49
Quarterly Debt To Equity0.00
LGND quarterly debt to equity ratio is 0.00
Quarterly Book Value$841.18 M
LGND quarterly book value is $841.18 million
Quarterly Working Capital$284.62 M
LGND quarterly working capital is $284.62 million

LGND Quarterly Quick Ratio Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LGND Quick Ratio Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+402.8%-17.8%
3 y3 years+168.3%+8.6%
5 y5 years+21.1%-63.7%

LGND Quick Ratio High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+402.8%-38.8%+819.2%
5 y5 years-80.6%+402.8%-81.8%+819.2%
alltimeall time-80.6%+2300.0%-81.8%+4496.1%

Ligand Pharmaceuticals Incorporated Quick Ratio History

DateAnnualQuarterly
Sept 2024
-
11.95(-25.5%)
June 2024
-
16.04(-17.8%)
Mar 2024
-
19.51(+53.4%)
Dec 2023
12.72(+402.8%)
12.72(-12.5%)
Sept 2023
-
14.54(+71.1%)
June 2023
-
8.50(+167.3%)
Mar 2023
-
3.18(+25.7%)
Dec 2022
2.53(-75.9%)
2.53(+73.3%)
Sept 2022
-
1.46(+12.3%)
June 2022
-
1.30(-77.9%)
Mar 2022
-
5.88(-44.0%)
Dec 2021
10.50(+121.5%)
10.50(-4.5%)
Sept 2021
-
11.00(+55.6%)
June 2021
-
7.07(+69.1%)
Mar 2021
-
4.18(-11.8%)
Dec 2020
4.74(-92.8%)
4.74(-76.3%)
Sept 2020
-
19.96(-32.1%)
June 2020
-
29.38(-27.1%)
Mar 2020
-
40.29(-38.6%)
Dec 2019
65.66(+525.3%)
65.66(+99.2%)
Sept 2019
-
32.96(+150.6%)
June 2019
-
13.15(+57.9%)
Mar 2019
-
8.33(-20.7%)
Dec 2018
10.50(+982.5%)
10.50(+379.5%)
Sept 2018
-
2.19(-5.6%)
June 2018
-
2.32(+69.3%)
Mar 2018
-
1.37(+41.2%)
Dec 2017
0.97(+36.6%)
0.97(+2.1%)
Sept 2017
-
0.95(+13.1%)
June 2017
-
0.84(+13.5%)
Mar 2017
-
0.74(+4.2%)
Dec 2016
0.71(-26.0%)
0.71(+18.3%)
Sept 2016
-
0.60(+7.1%)
June 2016
-
0.56(-94.8%)
Mar 2016
-
10.73(+1017.7%)
Dec 2015
0.96(-88.2%)
0.96(-92.5%)
Sept 2015
-
12.87(+17.9%)
June 2015
-
10.92(+5.0%)
Mar 2015
-
10.40(+28.1%)
Dec 2014
8.12(+902.5%)
8.12(-24.2%)
Sept 2014
-
10.71(+618.8%)
June 2014
-
1.49(-0.7%)
Mar 2014
-
1.50(+85.2%)
Dec 2013
0.81
0.81(+76.1%)
Sept 2013
-
0.46(+21.1%)
DateAnnualQuarterly
June 2013
-
0.38(-15.6%)
Mar 2013
-
0.45(-27.4%)
Dec 2012
0.62(-12.7%)
0.62(+24.0%)
Sept 2012
-
0.50(-16.7%)
June 2012
-
0.60(-26.8%)
Mar 2012
-
0.82(+15.5%)
Dec 2011
0.71(-36.0%)
0.71(+20.3%)
Sept 2011
-
0.59(-1.7%)
June 2011
-
0.60(-1.6%)
Mar 2011
-
0.61(-45.0%)
Dec 2010
1.11(-18.4%)
1.11(-18.4%)
Dec 2006
1.36(+156.6%)
1.36(+423.1%)
Sept 2006
-
0.26(-33.3%)
June 2006
-
0.39(-4.9%)
Mar 2006
-
0.41(-22.6%)
Dec 2005
0.53(-28.4%)
0.53(+8.2%)
Sept 2005
-
0.49(+2.1%)
June 2005
-
0.48(-17.2%)
Mar 2005
-
0.58(-21.6%)
Dec 2004
0.74(-11.9%)
0.74(-53.5%)
Sept 2004
-
1.59(-8.6%)
June 2004
-
1.74(-13.4%)
Mar 2004
-
2.01(+139.3%)
Dec 2003
0.84(-64.6%)
0.84(-61.1%)
Sept 2003
-
2.16(+45.9%)
June 2003
-
1.48(-2.6%)
Mar 2003
-
1.52(-35.9%)
Dec 2002
2.37(+51.0%)
2.37(+45.4%)
Sept 2002
-
1.63(-12.4%)
June 2002
-
1.86(+200.0%)
Mar 2002
-
0.62(-60.5%)
Dec 2001
1.57(+14.6%)
1.57(-17.4%)
Sept 2001
-
1.90(-8.7%)
June 2001
-
2.08(-9.6%)
Mar 2001
-
2.30(+67.9%)
Dec 2000
1.37(-44.3%)
1.37(-18.5%)
Sept 2000
-
1.68(-18.0%)
June 2000
-
2.05(-12.4%)
Mar 2000
-
2.34(-4.9%)
Dec 1999
2.46(-7.9%)
2.46(-3.5%)
Sept 1999
-
2.55(+40.9%)
June 1999
-
1.81(-30.7%)
Mar 1999
-
2.61(-2.2%)
Dec 1998
2.67
2.67(+12.2%)
Sept 1998
-
2.38

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual quick ratio?
  • What is the all time high annual quick ratio for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual quick ratio year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly quick ratio?
  • What is the all time high quarterly quick ratio for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly quick ratio year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual quick ratio?

The current annual quick ratio of LGND is 12.72

What is the all time high annual quick ratio for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual quick ratio is 65.66

What is Ligand Pharmaceuticals Incorporated annual quick ratio year-on-year change?

Over the past year, LGND annual quick ratio has changed by +10.19 (+402.77%)

What is Ligand Pharmaceuticals Incorporated quarterly quick ratio?

The current quarterly quick ratio of LGND is 11.95

What is the all time high quarterly quick ratio for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly quick ratio is 65.66

What is Ligand Pharmaceuticals Incorporated quarterly quick ratio year-on-year change?

Over the past year, LGND quarterly quick ratio has changed by -2.59 (-17.81%)